Citation Impact
Citing Papers
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
2009
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption
2006 StandoutNobel
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
Pilot Study of a Specific Dietary Supplement inTumor-Bearing Mice and in Stage IIIB and IV Non-Small Cell Lung Cancer Patients
2001
Prognostic Factors in Non-small Cell Lung Cancer
2002
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
2007
Osteoporosis
2019 Standout
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Chemotherapy for small cell lung cancer
2003
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice
2003
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
Cellular Oxidative Processes in Relation to Renal Disease
2005
Phase I/II Study of a 3 Weekly Oral Taxane (DJ-927) in Patients with Recurrent, Advanced Non-small Cell Lung Cancer
2008
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
2009
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
HLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis
2010 StandoutNobel
The Human Obesity Gene Map: The 2005 Update
2006
Reduction in Blood Pressure with a Sodium-Reduced, Potassium- and Magnesium-Enriched Mineral Salt in Subjects with Mild Essential Hypertension.
1998
Lung Cancer
2008 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2
2005
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial
1996
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
2010
Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects
2001
Worldwide prevalence and incidence of osteoporotic vertebral fractures
2017
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Racial and Genetic Factors in IgA Nephropathy
2008
The Kidney, Hypertension, and Remaining Challenges
2009
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
1997
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Dengue Epidemiology: Virus Epidemiology, Ecology, And Emergence
2003
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923
2002
Double-Cycle, High-Dose Ifosfamide, Carboplatin, and Etoposide Followed by Peripheral Blood Stem-Cell Transplantation for Small Cell Lung Cancer
2005
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Microtubules as a target for anticancer drugs
2004 Standout
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Phase I/II Study of Stage III and IV Non-Small Cell Lung Cancer Patients Taking a Specific Dietary Supplement
1999
The Human Obesity Gene Map: The 2003 Update
2004
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension
2003
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
2004
CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake
2005
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
2007 Standout
Small-cell lung cancer
2005
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
2007 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Clinical implication of symptoms in patients with non-small cell lung cancer treated with definitive radiation therapy
1995
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
2020 Standout
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer
2003
The Human Obesity Gene Map: The 2004 Update
2005
Adipose Tissue as an Endocrine Organ
2004 Standout
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy
2009
Small-cell lung cancer
2011
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Genetics of the metabolic syndrome
2007
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases
2003 Standout
Chemotherapy of advanced non-small cell lung cancer
1999
Guidelines for the Primary Prevention of Stroke
2014 Standout
A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
2006
Artificial Intelligence in Dentistry: Chances and Challenges
2020 Standout
Low-Sodium Dietary Approaches to Stop Hypertension Diet Reduces Blood Pressure, Arterial Stiffness, and Oxidative Stress in Hypertensive Heart Failure With Preserved Ejection Fraction
2012
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy
2004
Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer
2000
Endothelial Dysfunction in Salt-Sensitive Essential Hypertension
2001
Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer
2008
Carotid and Femoral Artery Stiffness in Relation to Three Candidate Genes in a White Population
2001
HYPERTENSION: Trends in Prevalence, Incidence, and Control
2006
Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel
2005
The Metabolic Syndrome
2008 Standout
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Pharmacogenomics of hypertension.
2003
Works of V. Giner being referenced
Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study
2010
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
2007
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
1996
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
1998
Prognostic factors in non-small cell lung cancer
1994
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
1996
The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain (the FRAVO Study)
2010
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
2007
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer
1994
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
2001
Lack of correlation between two methods for the assessment of salt sensitivity in essential hypertension
2002
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy
2004
Microalbuminuria and oxidative stress in essential hypertension
2004
ASSOCIATION OF THE G PROTEINβ3 SUBUNIT T ALLELE WITH INSULIN RESISTANCE IN ESSENTIAL HYPERTENSION
2002
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
1999
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
1997
[Dengue: a re-emerging disease. A clinical and epidemiological study in 57 Spanish travelers].
1998
A randomized trial comparing in small cell lung cancer (SCLC) induction chemotherapy by ifosfamide and etoposide with adriamycin (IVA) or epirubicine (IVE): An European lung cancer working party report
1993
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
1994
Molecular Basis of Salt Sensitivity in Human Hypertension
2001
Fluid, Ionic and Hormonal Changes Induced by High Salt Intake in Salt-Sensitive and Salt-Resistant Hypertensive Patients
1996
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: Experience of the European Lung Cancer Working Party
1995
Renin-Angiotensin System Genetic Polymorphisms and Salt Sensitivity in Essential Hypertension
2000
A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC)
2006